Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites

M. M. Stanley, S. Ochi, K. K. Lee, B. A. Nemchausky, H. B. Greenlee, J. I. Allen, M. J. Allen, R. A. Baum, T. R. Gadacz, D. S. Camara, J. A. Caruana, Eugene R Schiff, Alan Livingstone, A. K. Samanta, A. Z. Najem, M. E. Glick, G. L. Juler, N. Adham, J. D. Baker

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

The optimal management of severe ascites in patients with alcoholic cirrhosis has not been defined. In a 5 1/2 -year study, we randomly assigned 299 men with alcoholic cirrhosis, who had persistent or recurrent severe ascites despite a standard medical regimen, to receive either intensive medical treatment or peritoneovenous (LeVeen) shunting. We identified three risk groups: Group 1 had normal or mildly abnormal results on liver-function tests, Group 2 had more severe liver dysfunction or previous complications, and Group 3 had severe prerenal azotemia without kidney disease. For the patients who received the medical treatment and those who received the surgical treatment combined, the median survival times were 1093 in Group 1, 222 days in Group 2, and 37 days in Group 3 (P ≤ 0.01 for all comparisons). For all the groups combined, the median time to the resolution of ascites was 5.4 weeks for medical patients and 3.0 weeks for surgical patients (P < 0.01). Within each risk group, mortality during the initial hospitalization and median long-term survival were similar among patients receiving either treatment. However, the median time to the recurrence of ascites in Group 1 was 4 months in medical patients, as compared with 18 months in surgical patients (P = 0.01); in Group 2 it was 3 months in medical patients as compared with 12 months in surgical patients (P = 0.04). The median duration of hospitalization was longer in medical patients than in surgical patients (6.1 vs. 2.4 weeks in Group 1 [P < 0.001] and 5.0 vs. 3.1 weeks in Group 2 [P < 0.01]). Group 3 was too small to permit a meaningful comparison. During the initial hospitalization, the incidence of infections, gastrointestinal bleeding, and encephalopathy was similar among the medical and surgical patients. We conclude that peritoneovenous shunting alleviated disabling ascites more rapidly than medical management. However, survival was closely related to the severity of the illness at the time of randomization and was not altered by shunting.

Original languageEnglish
Pages (from-to)1632-1638
Number of pages7
JournalNew England Journal of Medicine
Volume321
Issue number24
StatePublished - Dec 1 1989
Externally publishedYes

Fingerprint

Alcoholic Liver Cirrhosis
Ascites
Therapeutics
Hospitalization
Survival
Azotemia
Liver Function Tests
Kidney Diseases
Brain Diseases
Random Allocation
Liver Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stanley, M. M., Ochi, S., Lee, K. K., Nemchausky, B. A., Greenlee, H. B., Allen, J. I., ... Baker, J. D. (1989). Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. New England Journal of Medicine, 321(24), 1632-1638.

Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. / Stanley, M. M.; Ochi, S.; Lee, K. K.; Nemchausky, B. A.; Greenlee, H. B.; Allen, J. I.; Allen, M. J.; Baum, R. A.; Gadacz, T. R.; Camara, D. S.; Caruana, J. A.; Schiff, Eugene R; Livingstone, Alan; Samanta, A. K.; Najem, A. Z.; Glick, M. E.; Juler, G. L.; Adham, N.; Baker, J. D.

In: New England Journal of Medicine, Vol. 321, No. 24, 01.12.1989, p. 1632-1638.

Research output: Contribution to journalArticle

Stanley, MM, Ochi, S, Lee, KK, Nemchausky, BA, Greenlee, HB, Allen, JI, Allen, MJ, Baum, RA, Gadacz, TR, Camara, DS, Caruana, JA, Schiff, ER, Livingstone, A, Samanta, AK, Najem, AZ, Glick, ME, Juler, GL, Adham, N & Baker, JD 1989, 'Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites', New England Journal of Medicine, vol. 321, no. 24, pp. 1632-1638.
Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. New England Journal of Medicine. 1989 Dec 1;321(24):1632-1638.
Stanley, M. M. ; Ochi, S. ; Lee, K. K. ; Nemchausky, B. A. ; Greenlee, H. B. ; Allen, J. I. ; Allen, M. J. ; Baum, R. A. ; Gadacz, T. R. ; Camara, D. S. ; Caruana, J. A. ; Schiff, Eugene R ; Livingstone, Alan ; Samanta, A. K. ; Najem, A. Z. ; Glick, M. E. ; Juler, G. L. ; Adham, N. ; Baker, J. D. / Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. In: New England Journal of Medicine. 1989 ; Vol. 321, No. 24. pp. 1632-1638.
@article{846411d77d4d4a5dabf9df8faa93a8b9,
title = "Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites",
abstract = "The optimal management of severe ascites in patients with alcoholic cirrhosis has not been defined. In a 5 1/2 -year study, we randomly assigned 299 men with alcoholic cirrhosis, who had persistent or recurrent severe ascites despite a standard medical regimen, to receive either intensive medical treatment or peritoneovenous (LeVeen) shunting. We identified three risk groups: Group 1 had normal or mildly abnormal results on liver-function tests, Group 2 had more severe liver dysfunction or previous complications, and Group 3 had severe prerenal azotemia without kidney disease. For the patients who received the medical treatment and those who received the surgical treatment combined, the median survival times were 1093 in Group 1, 222 days in Group 2, and 37 days in Group 3 (P ≤ 0.01 for all comparisons). For all the groups combined, the median time to the resolution of ascites was 5.4 weeks for medical patients and 3.0 weeks for surgical patients (P < 0.01). Within each risk group, mortality during the initial hospitalization and median long-term survival were similar among patients receiving either treatment. However, the median time to the recurrence of ascites in Group 1 was 4 months in medical patients, as compared with 18 months in surgical patients (P = 0.01); in Group 2 it was 3 months in medical patients as compared with 12 months in surgical patients (P = 0.04). The median duration of hospitalization was longer in medical patients than in surgical patients (6.1 vs. 2.4 weeks in Group 1 [P < 0.001] and 5.0 vs. 3.1 weeks in Group 2 [P < 0.01]). Group 3 was too small to permit a meaningful comparison. During the initial hospitalization, the incidence of infections, gastrointestinal bleeding, and encephalopathy was similar among the medical and surgical patients. We conclude that peritoneovenous shunting alleviated disabling ascites more rapidly than medical management. However, survival was closely related to the severity of the illness at the time of randomization and was not altered by shunting.",
author = "Stanley, {M. M.} and S. Ochi and Lee, {K. K.} and Nemchausky, {B. A.} and Greenlee, {H. B.} and Allen, {J. I.} and Allen, {M. J.} and Baum, {R. A.} and Gadacz, {T. R.} and Camara, {D. S.} and Caruana, {J. A.} and Schiff, {Eugene R} and Alan Livingstone and Samanta, {A. K.} and Najem, {A. Z.} and Glick, {M. E.} and Juler, {G. L.} and N. Adham and Baker, {J. D.}",
year = "1989",
month = "12",
day = "1",
language = "English",
volume = "321",
pages = "1632--1638",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "24",

}

TY - JOUR

T1 - Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites

AU - Stanley, M. M.

AU - Ochi, S.

AU - Lee, K. K.

AU - Nemchausky, B. A.

AU - Greenlee, H. B.

AU - Allen, J. I.

AU - Allen, M. J.

AU - Baum, R. A.

AU - Gadacz, T. R.

AU - Camara, D. S.

AU - Caruana, J. A.

AU - Schiff, Eugene R

AU - Livingstone, Alan

AU - Samanta, A. K.

AU - Najem, A. Z.

AU - Glick, M. E.

AU - Juler, G. L.

AU - Adham, N.

AU - Baker, J. D.

PY - 1989/12/1

Y1 - 1989/12/1

N2 - The optimal management of severe ascites in patients with alcoholic cirrhosis has not been defined. In a 5 1/2 -year study, we randomly assigned 299 men with alcoholic cirrhosis, who had persistent or recurrent severe ascites despite a standard medical regimen, to receive either intensive medical treatment or peritoneovenous (LeVeen) shunting. We identified three risk groups: Group 1 had normal or mildly abnormal results on liver-function tests, Group 2 had more severe liver dysfunction or previous complications, and Group 3 had severe prerenal azotemia without kidney disease. For the patients who received the medical treatment and those who received the surgical treatment combined, the median survival times were 1093 in Group 1, 222 days in Group 2, and 37 days in Group 3 (P ≤ 0.01 for all comparisons). For all the groups combined, the median time to the resolution of ascites was 5.4 weeks for medical patients and 3.0 weeks for surgical patients (P < 0.01). Within each risk group, mortality during the initial hospitalization and median long-term survival were similar among patients receiving either treatment. However, the median time to the recurrence of ascites in Group 1 was 4 months in medical patients, as compared with 18 months in surgical patients (P = 0.01); in Group 2 it was 3 months in medical patients as compared with 12 months in surgical patients (P = 0.04). The median duration of hospitalization was longer in medical patients than in surgical patients (6.1 vs. 2.4 weeks in Group 1 [P < 0.001] and 5.0 vs. 3.1 weeks in Group 2 [P < 0.01]). Group 3 was too small to permit a meaningful comparison. During the initial hospitalization, the incidence of infections, gastrointestinal bleeding, and encephalopathy was similar among the medical and surgical patients. We conclude that peritoneovenous shunting alleviated disabling ascites more rapidly than medical management. However, survival was closely related to the severity of the illness at the time of randomization and was not altered by shunting.

AB - The optimal management of severe ascites in patients with alcoholic cirrhosis has not been defined. In a 5 1/2 -year study, we randomly assigned 299 men with alcoholic cirrhosis, who had persistent or recurrent severe ascites despite a standard medical regimen, to receive either intensive medical treatment or peritoneovenous (LeVeen) shunting. We identified three risk groups: Group 1 had normal or mildly abnormal results on liver-function tests, Group 2 had more severe liver dysfunction or previous complications, and Group 3 had severe prerenal azotemia without kidney disease. For the patients who received the medical treatment and those who received the surgical treatment combined, the median survival times were 1093 in Group 1, 222 days in Group 2, and 37 days in Group 3 (P ≤ 0.01 for all comparisons). For all the groups combined, the median time to the resolution of ascites was 5.4 weeks for medical patients and 3.0 weeks for surgical patients (P < 0.01). Within each risk group, mortality during the initial hospitalization and median long-term survival were similar among patients receiving either treatment. However, the median time to the recurrence of ascites in Group 1 was 4 months in medical patients, as compared with 18 months in surgical patients (P = 0.01); in Group 2 it was 3 months in medical patients as compared with 12 months in surgical patients (P = 0.04). The median duration of hospitalization was longer in medical patients than in surgical patients (6.1 vs. 2.4 weeks in Group 1 [P < 0.001] and 5.0 vs. 3.1 weeks in Group 2 [P < 0.01]). Group 3 was too small to permit a meaningful comparison. During the initial hospitalization, the incidence of infections, gastrointestinal bleeding, and encephalopathy was similar among the medical and surgical patients. We conclude that peritoneovenous shunting alleviated disabling ascites more rapidly than medical management. However, survival was closely related to the severity of the illness at the time of randomization and was not altered by shunting.

UR - http://www.scopus.com/inward/record.url?scp=0024799193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024799193&partnerID=8YFLogxK

M3 - Article

C2 - 2586565

AN - SCOPUS:0024799193

VL - 321

SP - 1632

EP - 1638

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 24

ER -